Mineralys Therapeutics, Inc. (MLYS)
NASDAQ: MLYS · Real-Time Price · USD
12.34
+0.51 (4.31%)
Dec 20, 2024, 4:00 PM EST - Market closed
Mineralys Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '24 Dec 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 614 | 354 | - | - | - |
| Enterprise Value | 351 | 100 | - | - | - |
| Last Close Price | 12.34 | 8.60 | - | - | - |
| PB Ratio | 2.59 | 1.47 | - | - | - |
| P/TBV Ratio | 2.54 | 1.47 | - | - | - |
| Debt / Equity Ratio | - | - | - | - | -1.25 |
| Quick Ratio | 8.42 | 22.57 | 13.65 | 2.10 | 0.28 |
| Current Ratio | 8.55 | 23.76 | 13.98 | 2.20 | 0.29 |
| Return on Equity (ROE) | -61.19% | -41.38% | -53.00% | -1568.96% | - |
| Return on Assets (ROA) | -38.55% | -28.91% | -31.34% | -185.60% | - |
| Return on Capital (ROIC) | -42.01% | -30.45% | -34.99% | -335.62% | - |
| Earnings Yield | -24.95% | -20.34% | - | - | - |
| FCF Yield | -20.93% | -22.96% | - | - | - |
| Buyback Yield / Dilution | -67.83% | -600.33% | -3.67% | -7.64% | - |
| Total Shareholder Return | -67.83% | -600.33% | -3.67% | -7.64% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.